New York State Common Retirement Fund Cytom X Therapeutics, Inc. Transaction History

New York State Common Retirement Fund

$73.9 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$1.53 - $2.89 $46,141 - $87,156	-30,158 Reduced 98.55%	445 $1,000
Q1 2022 May 05, 2022	BUY	$2.67 - $4.68 $242 - $425	91 Added 0.3%	30,603 $82,000
Q4 2021 Feb 02, 2022	SELL	$3.87 - $7.39 $553 - $1,056	-143 Reduced 0.47%	30,512 $132,000
Q3 2021 Nov 02, 2021	SELL	$4.32 - $6.43 $81,336 - $121,064	-18,828 Reduced 38.05%	30,655 $156,000
Q2 2021 Aug 02, 2021	BUY	$6.33 - $9.91 $41,037 - $64,246	6,483 Added 15.08%	49,483 $313,000
Q1 2021 May 11, 2021	SELL	$6.6 - $9.0 $60,238 - $82,143	-9,127 Reduced 17.51%	43,000 $332,000
Q4 2020 Feb 08, 2021	SELL	$6.47 - $7.9 $89,933 - $109,810	-13,900 Reduced 21.05%	52,127 $341,000
Q2 2020 Aug 07, 2020	BUY	$7.4 - $14.64 $136,774 - $270,591	18,483 Added 38.88%	66,027 $550,000
Q1 2020 May 06, 2020	SELL	$3.61 - $8.6 $6,797 - $16,193	-1,883 Reduced 3.81%	47,544 $365,000
Q4 2019 Feb 05, 2020	SELL	$5.17 - $8.91 $7,238 - $12,474	-1,400 Reduced 2.75%	49,427 $411,000
Q3 2019 Nov 07, 2019	BUY	$7.38 - $12.25 $8,856 - $14,700	1,200 Added 2.42%	50,827 $375,000
Q2 2019 Aug 09, 2019	SELL	$9.35 - $11.41 $3,272 - $3,993	-350 Reduced 0.7%	49,627 $557,000
Q1 2019 May 08, 2019	SELL	$9.5 - $19.16 $5,225 - $10,538	-550 Reduced 1.09%	49,977 $537,000
Q4 2018 Feb 08, 2019	SELL	$12.69 - $18.61 $15,862 - $23,262	-1,250 Reduced 2.41%	50,527 $763,000
Q3 2018 Nov 07, 2018	SELL	$18.04 - $26.41 $104,632 - $153,178	-5,800 Reduced 10.07%	51,777 $958,000
Q2 2018 Aug 10, 2018	BUY	$21.38 - $29.68 $228,338 - $316,982	10,680 Added 22.77%	57,577 $1.32 Million
Q1 2018 May 10, 2018	BUY	$21.76 - $34.22 $96,179 - $151,252	4,420 Added 10.41%	46,897 $1.33 Million
Q4 2017 Feb 13, 2018	BUY	$19.0 - $23.09 $105,963 - $128,772	5,577 Added 15.11%	42,477 $897,000
Q3 2017 Nov 06, 2017	BUY	$13.53 - $18.17 $78,474 - $105,386	5,800 Added 18.65%	36,900 $670,000
Q2 2017 Aug 11, 2017	BUY	N/A	31,100	31,100 $482,000

Others Institutions Holding CTMX

# of Institutions

Shares Held

50.7M

Call Options Held

112K

Put Options Held

8.3K

Tang Capital Management LLC San Diego, CA

7.81M
Shares

$8.28 Million
0.79% of portfolio
Bvf Inc San Francisco, CA

5.23M
Shares

$5.54 Million
0.2% of portfolio
Vanguard Group Inc Valley Forge, PA

5.16M
Shares

$5.47 Million
0.0% of portfolio
Janus Henderson Group PLC London, X0

4.81M
Shares

$5.1 Million
0.0% of portfolio
Acadian Asset Management LLC Boston, MA

3.1M
Shares

$3.29 Million
0.01% of portfolio

View Full List

About CytomX Therapeutics, Inc.

Ticker CTMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,950,200
Market Cap $69.9M
Description
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...

More about CTMX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.

Account